Skip to content

A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.

To Evaluate the Efficacy and safety of Tablet Bhoumya and Tablet Saathmya as an add-on Therapy to Standard of Care in COVID-19 Positive Patients. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025671
Enrollment
10
Registered
2020-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Tablet Bhoumya Tablet Saathmya: Tablet Bhoumya 600mg Tablet Saathmya 500mg 2 tablets each, 3 times a day, after food for 15 days as add-on therapy in addition to standard care of treat

Sponsors

Dr Giridhara Kaje
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients ready to give informed consent COVID-19 Test - +ve Patients who can take oral medicine. Patients aged >18 years both male and female Uncomplicated illness and Mild Pneumonia Cases

Exclusion criteria

Exclusion criteria: Patients not ready to give informed consent Pregnant women and lactating mother Peadiatric patients 0-18 years Severe Pneumonia, Acute Respiratory Distress Syndrome, Sepsis & Septic Shock cases

Design outcomes

Primary

MeasureTime frame
1.Time in days for Clinical cure:Stable normal clinical temperature and vitals in 3-5-7-10-14 days. 2.Time in days till RT-PCR is negative . 3.Rate of improvement of IL-6 levels at 0-7-14 days as compared to baseline. Timepoint: From the baseline till the end of 15 days.

Secondary

MeasureTime frame
1.Length of stay in hospital. 2.Rate of clinical cure at 5-7-10-14 days. 3.Rate of RT-PCR negativity at 5-7-10-14 days. 4.Rate of improvement in chest X-ray at 5-7-10-14 days. 5.Rate of patients ending up with severe pneumonia. Timepoint: From the baseline till the end of 1 month.

Countries

India

Contacts

Public ContactDr Harish M

Prashanthi Ayurvedic Centre

prashanthiayurvedic@gmail.com9845557105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026